StoneX Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-7,005
| Closed | -$647K | – | 413 |
|
|
2024
Q2 | $647K | Buy |
7,005
+122
| +2% | +$11.3K | 0.3% | 80 |
|
|
2024
Q1 | $658K | Buy |
6,883
+1,149
| +20% | +$110K | 0.34% | 73 |
|
|
2023
Q4 | $437K | Buy |
5,734
+2,009
| +54% | +$153K | 0.23% | 114 |
|
|
2023
Q3 | $258K | Buy |
3,725
+916
| +33% | +$63.5K | 0.14% | 222 |
|
|
2023
Q2 | $265K | Buy |
2,809
+120
| +4% | +$11.3K | 0.15% | 215 |
|
|
2023
Q1 | $222K | Buy |
+2,689
| New | +$222K | 0.13% | 258 |
|
|
2022
Q3 | – | Sell |
-2,719
| Closed | -$259K | – | 400 |
|
|
2022
Q2 | $259K | Sell |
2,719
-810
| -23% | -$77K | 0.04% | 279 |
|
|
2022
Q1 | $415K | Buy |
+3,529
| New | +$415K | 0.04% | 349 |
|